TheraCell's board of directors appointed Gunnar B.J. Andersson, MD, PhD, as director of the company and member of the surgeon advisory board.
"Dr. Andersson's 45 years of board experience across both clinical and commercial aspects of the industry will add a valuable perspective to our board of directors," said Chairman and CEO Bradley E. Patt, PhD. "We appreciate his willingness to serve as a director and look forward to benefiting from his judgment and input."
Here are five key notes:
1. There are now five directors on TheraCell's board, and two of them are spine surgeons.
2. Dr. Andersson is the Ronald L. DeWald, M.D. Professor and Chairman Emeritus of the department of orthopedic surgery at Rush University Medical Center and a Spine, Back & Neck Surgeon at Midwest Orthopaedics at Rush.
3. TheraCell is a regenerative medicine company developing the next generation of advanced technologies for tissue repair with three synergistic technology platforms.
4. Dr. Andersson has been a member of the scientific advisory boards at several companies, including Zimmer, Smith & Nephew, Pioneer and Oratec. He is currently on the scientific advisory boards for Alloscource, Ouroboros, Biomatcell and Spinal Kinetics.
5. United Healthcare also named Dr. Andersson to the spine advisory board.
"TheraCell has become an exciting and promising company and I am delighted to participate," said Dr. Andersson. "They have developed an exciting new platform of demineralized bone fiber products and are partnering with a well-established tissue bank to take these initial products to market. These initiatives will help accelerate revenues and give the company credibility. I like the idea of oxygenating the demineralized bone fiber matrix to help cells survive in a deep graft."